Mucosal and systemic immunization against tuberculosis by ISCOMATRIX nano adjuvant co-administered with alginate coated chitosan nanoparticles

OBJECTIVE(S): BCG vaccine has no longer been appreciated to immunize against tuberculosis, worldwide, so novel appropriate adjuvants have been dedicated to improve immune responses. This study aimed to evaluate the immunomodulatory effects of ISCOMATRIX as an adjuvant to stimulate potent humoral and...

Descripción completa

Detalles Bibliográficos
Autores principales: Najafi, Adel, Ghazvini, Kiarash, Sankian, Mojtaba, Gholami, Leila, Zare, Sirwan, Yousefi Arvand, Arshid, Tafaghodi, Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510487/
https://www.ncbi.nlm.nih.gov/pubmed/37736514
http://dx.doi.org/10.22038/IJBMS.2023.67564.14806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510487/
https://www.ncbi.nlm.nih.gov/pubmed/37736514
http://dx.doi.org/10.22038/IJBMS.2023.67564.14806

Ejemplares similares